Shemesh Shay (CIK 0001896056)

Latest company ownership

NVCT - Nuvectis Pharma, Inc.

Role: Chief Dev. & Ops. Officer

Shares held

1,643,068

Last filed at

Jan 3, 2025

Confidence Score

50.0

2025Q4

Confidence Score History

2022Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
May 10, 2024	May 13, 2024	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	55.0	+1,113	0.07%	✗	$7K
Mar 21, 2023	Mar 22, 2023	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+420	0.03%	✗	$5K
Mar 15, 2023	Mar 17, 2023	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+670	0.05%	✗	$7.2K
Dec 21, 2022	Dec 22, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+500	0.04%	✗	$3.8K
Nov 16, 2022	Nov 18, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+300	0.02%	✗	$2.1K
Sep 23, 2022	Sep 27, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+220	0.02%	✗	$1.7K
Sep 2, 2022	Sep 6, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+404	0.03%	✗	$3.4K
Aug 31, 2022	Sep 2, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	61.3	+3,006	0.24%	✗	$24.3K
May 20, 2022	May 23, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+300	0.02%	✗	$5K
May 16, 2022	May 18, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	47.5	+242	0.02%	✗	$4.7K
May 12, 2022	May 13, 2022	Nuvectis Pharma, Inc.	Chief Dev. & Ops. Officer	Buy	56.3	+1,278	0.10%	✗	$20.3K
Feb 4, 2022	Feb 8, 2022	Nuvectis Pharma, Inc.	Chief Development Officer	Buy	61.3	+2,946	0.25%	✗	$10K